Riskpilot← Back to searchSign inGet full accessCHEMVET DK A/S
A/SActiveCVR 11988237A.C.Illums Vej 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198814 employees
Revenue 2024
DKK 33,4M
+31% vs 2023
EBITDA margin
76.4%
+37% vs 2023
Equity ratio
71.2%
Financial strength
Net profit 2024
DKK 19,5M
+38% vs 2023
| Revenue | DKK 33,4M | +31% |
| EBITDA | DKK 25,5M | +37% |
| Net profit | DKK 19,5M | +38% |
| Total assets | DKK 37,3M | +15% |
| Equity | DKK 26,5M | +26% |
| Employees | 14 | — |
Legal name
CHEMVET DK A/S
CVR number
11988237
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. marts 1988
Share capital
DKK 500.000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af en direktør alene
Company purpose
Selskabets formål er at drive handel og industri
Address
A.C.Illums Vej 6
Phone
+4586817522
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20.565 | 26.095 | 24.654 | 25.502 | 33.425 |
| Staff expenses | -7.118 | -6.066 | -6.580 | -6.858 | -7.899 |
| EBITDA | 13.447 | 20.029 | 18.074 | 18.644 | 25.526 |
| Depreciation & amort. | -289 | -718 | -706 | -666 | -710 |
| EBIT | 13.158 | 19.311 | 17.368 | 17.978 | 24.816 |
| Net financials | -65 | -190 | -141 | 125 | 246 |
| Profit before tax | 13.093 | 19.121 | 17.227 | 18.102 | 25.062 |
| Tax | 2.889 | 4.214 | 3.795 | 3.991 | 5.528 |
| Net profit | 10.204 | 14.908 | 13.432 | 14.112 | 19.535 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30.577 | 34.426 | 29.669 | 32.307 | 37.258 |
| Equity | 17.542 | 20.450 | 19.882 | 20.994 | 26.529 |
| Long-term debt | 3.968 | 3.176 | 2.782 | 2.387 | 1.996 |
| Short-term debt | 8.817 | 10.477 | 6.649 | 8.574 | 8.396 |
| Total debt | 12.785 | 13.653 | 9.431 | 10.961 | 10.392 |
EBITDA margin
76.4%
This company
15.8%
Market median
+384% vs market
20202024
Equity ratio
71.2%
This company
38.2%
Market median
+86% vs market
20202024
Return on equity
73.6%
This company
18.4%
Market median
+300% vs market
20202024
Net profit margin
58.4%
This company
8.1%
Market median
+621% vs market
20202024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20202024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FA Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (4) | ||
ET | Audit | 1988 – 1988 |
PA Management | Management | 1988 – 2025 |
HK Audit | Audit | 1988 – 2003 |
PE Management | Management | 1988 – 1988 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2006 | |
| Former (4) | ||
| Board of Directors | 1988 – 1992 | |
| Board of Directors | 1988 – 1988 | |
| Board of Directors | 1988 – 2006 | |
| Chairman | 1988 – 1988 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 1988 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CHEMVET HOLDING ApS
CHEMVET DK A/S Board members of CHEMVET DK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| Peter Arvé Christensen | Management | 0 companies |
| Hans Kristian Carøe | Audit | 0 companies |
| Frank Arvé Christensen | Chief Executive Officer | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Lisbeth Revsbeck | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Board of Directors | 0 companies |
| Joan Kjærgaard Christensen | Board of Directors | 0 companies |
| Helene Arvé Christensen | Chairman | 0 companies |
| Susanne Saul Stakemann | Chairman | 0 companies |
| Sarah Arvé | Board of Directors | 0 companies |